Global scarcity and a life-changing cystic fibrosis drug | The Current

The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either unavailable or costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag. #Trikafta #CysticFibrosis #Heath »»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS Connect with CBC News Online: For breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX Follow CBC News on TikTok: https://bit.ly/3TnHioe Follow CBC News on Twitter: http://bit.ly/1sA5P9H Find CBC News on Facebook: http://bit.ly/1WjG36m Follow CBC News on Instagram: http://bit.ly/1Z0iE7O Subscribe to CBC News on Snapchat: https://bit.ly/3leaWsr Download the CBC News app for iOS: http://apple.co/25mpsUz Download the CBC News app for Android: http://bit.ly/1XxuozZ »»»»»»»»»»»»»»»»»» For more than 80 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.